TITLE

STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

AUTHOR(S)
Asselah, T.; Rubbia-Brandt, L.; Marcellin, P.; Negro, F.
PUB. DATE
January 2006
SOURCE
Gut;Jan2006, Vol. 55 Issue 1, p123
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Hepatic steatosis is a common histological feature of chronic hepatitis C. Various factors are associated with hepatic steatosis, including obesity, high alcohol consumption, diabetes type II, and hyperlipidaemia. These factors may contribute to steatosis in patients with chronic hepatitis C. In humans, hepatitis C virus (HCV) genotype 3 is more commonly associated with steatosis. In vitro studies and the transgenic mouse model have suggested that the HCV core protein (genotype 1) can induce lipid accumulation within hepatocytes. However, what is the relevance of steatosis in chronic hepatitis C? It seems that in certain populations, steatosis may be associated with fibrosis progression and this may be genotype specific. The mechanisms underlying this association are unknown; neither is it clear whether this holds true for all patients or only a subgroup. Indeed, alter antiviral treatment, virus related steatosis disappears whereas the host associated steatosis remains unaffected. This review describes and discusses the basic and clinical aspects of the relationship between steatosis and progression of fibrosis, and response to treatment in patients with chronic hepatitis C.
ACCESSION #
19623598

 

Related Articles

  • Hepatic steatosis and type 2 diabetes mellitus. Salas-Flores, Ricardo; González-Pérez, Brian; Echegollen-Guzmán, Alonso // Revista Medica del IMSS;2012, Vol. 50 Issue 1, p13 

    Background: patients with type 2 diabetes mellitus (T2DM) appear to have an increased risk of developing nonalcoholic fatty liver disease (NAFLD) and have higher risk to develop hepatic fibrosis and cirrhosis. The aim was to determine the prevalence of NAFLD in health workers with T2DM by liver...

  • Steatosis is a Lot More than Holes in Hepatocytes. Chakrabarti, Subrata // Saudi Journal of Gastroenterology;Jan2009, Vol. 15 Issue 1, p1 

    The article looks at the role of steatosis in chronic hepatitis C with reference to several studies. It cites that a study by A. Zubair et al published within the issue demonstrated the association between macrovesicular steatosis and fibrosis in liver disease. It adds that the study indicated...

  • Metabolism of diacylglycerol in humans. Takase, Hideto // Asia Pacific Journal of Clinical Nutrition;2007 Supplement 1, Vol. 16, p398 

    Obesity resides upstream of the constituents of metabolic syndromes such as diabetes, hypertension, hyperlipidemia, and arteriosclerosis. Postprandial hyperlipidemia is also implicated in atherogenesis. Therefore. factors that influence the body adiposity and the magnitude of postprandial...

  • Pathology of Nonalcoholic Fatty Liver Disease. Matthew Yeh; Elizabeth Brunt // American Journal of Clinical Pathology;Nov2007, Vol. 128 Issue 5, p837 

    Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are gaining increasing recognition as components of the emerging epidemic of obesity in North America and in other parts of the world. These entities are considered the hepatic manifestations of the insulin...

  • health handbook. Adams, Penny // Good Health & Medicine;Apr2007, p18 

    The article answers a question about fatty liver. Fatty liver refers to abnormal build-up of fat in liver cells and the problems causing this are excess alcohol, obesity and type 2 diabetes. It is important to treat the causes of fatty liver and avoid alcohol, as severe cases may progress to...

  • Metabolic Syndrome and Robustness Tradeoffs. Kitano, Hiroaki; Oda, Kanae; Kimura, Tomomi; Matsuoka, Yukiko; Csete, Marie; Doyle, John; Muramatsu, Masaaki // Diabetes;Dec2004 Supplement, Vol. 53, pS6 

    The metabolic syndrome is a highly complex breakdown of normal physiology characterized by obesity, insulin resistance, hyperlipidemia, and hypertension. Type 2 diabetes is a major manifestation of this syndrome, although increased risk for cardiovascular disease (CVD) often precedes the onset...

  • The Hepatoselective Glucokinase Activator PF-04991532 Ameliorates Hyperglycemia without Causing Hepatic Steatosis in Diabetic Rats. Erion, Derek M.; Lapworth, Amanda; Amor, Paul A.; Bai, Guoyun; Vera, Nicholas B.; Clark, Ronald W.; Yan, Qingyun; Zhu, Yimin; Ross, Trenton T.; Purkal, Julie; Gorgoglione, Matthew; Zhang, Guodong; Bonato, Vinicius; Baker, Levenia; Barucci, Nicole; D’Aquila, Theresa; Robertson, Alan; Aiello, Robert J.; Yan, Jiangli; Trimmer, Jeff // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Hyperglycemia resulting from type 2 diabetes mellitus (T2DM) is the main cause of diabetic complications such as retinopathy and neuropathy. A reduction in hyperglycemia has been shown to prevent these associated complications supporting the importance of glucose control. Glucokinase converts...

  • Sıklığı Artan Bir Halk SaÄŸlığı Sorunu: Non-Alkolik YaÄŸlı KaraciÄŸer Hastalığı. Kara, Muammer; Erdal, Muhammed // TAF Preventive Medicine Bulletin;2014, Vol. 13 Issue 1, p65 

    Non-alcoholic fatty liver disease (NAFLD), is a liver disease, that occur in non alcohol users, with same histological features of alcoholic liver disease. The increased importance of NAFLD is depends on its close relation of current problems such as Type 2 Diabetes Mellitus and hyperlipidemia,...

  • Sıklığı Artan Bir Halk SaÄŸlığı Sorunu: Non-Alkolik YaÄŸlı KaraciÄŸer Hastalığı. Kara, Muammer; Erdal, Muhammed // TAF Preventive Medicine Bulletin;Sep/Oct2011, Vol. 10 Issue 5, p593 

    Non-alcoholic fatty liver disease (NAFLD), is a liver disease, that occur in non alcohol users, with same histological features of alcoholic liver disease. The increased importance of NAFLD is depends on its close relation of current problems such as Type 2 Diabetes Mellitus and hyperlipidemia,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics